Federal government pushing two million vaccines to provinces in coming days - National Post | Canada News Media
Connect with us

Business

Federal government pushing two million vaccines to provinces in coming days – National Post

Published

 on


Maj.-Gen. Dany Fortin said ‘despite the bumps,’ Canada’s vaccine effort is going well now with deliveries set to continue at large volumes into the spring

Article content

OTTAWA – Provinces will receive two million doses of desperately needed vaccines in the days ahead, as the federal government pushes out the last of 9.5 million doses Canada has received so far.

The Liberals’ first target for the rollout was six million doses by the end of the first quarter, which it then increased to 9.5 million earlier this month. Pfizer has met its total and on Thursday the government was shipping 1.5 million doses of AstraZeneca that arrived from the United States to provinces. Nearly 600,000 doses of Moderna’s vaccine that were originally set to arrive last week, were set to land in Canada on Friday morning and be sent to provinces over the weekend.

Maj.-Gen. Dany Fortin said Canada’s vaccine effort is going well now with deliveries set to continue at large volumes into the spring.

“Despite the bumps Canada has seen over the last three months, it’s important to note some great successes along the way,” he said. “By the end of this week, we can expect to have distributed approximately 9.5 million COVID-19 vaccine doses across the country.”

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

Government officials speaking on background said the government was paying a premium to its shipping companies to get the newly arriving vaccines out quickly over the holiday weekend.

Announcing a one-month lockdown for his province that begins Saturday, Ontario Premier Doug Ford was less critical of the federal government’s rollout than he has been recently.

He said he was confident millions of doses would arrive in his province in the coming months and the province had to close down so the vaccines could catch up.

“We need more time for our vaccine program to take hold,” he said. “We need more runway to let our vaccination rollout get to where we need it.”


  1. AstraZeneca COVID shots could test Canadians’ vaccine hesitancy: ‘There is no way they can downplay that risk’


  2. Ontario imposes four-week provincewide ‘shutdown’ to combat spike in COVID-19 cases

Fortin announced 300,000 doses of the AstraZeneca vaccine would also be arriving next week, through the COVAX facility. COVAX is an international partnership that has developing countries purchase vaccines for both themselves and the developing world. Canada is one of a few developed nations to actually draw on the facility.

There are another 1.5 million doses of AstraZeneca coming from the Serum Institute, an Indian manufacturer. A million of those doses were set to arrive in mid-April, and another 500,000 in May.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

Joelle Paquette, a director general with Public Services and Procurement Canada said they were expecting a delay, but could not provide any more details on that shortage.

“We’re working with the company on determining when the doses will arrive. We are expecting a delay in the shipment, but they are committed to meeting their contractual obligations,” she said.

As COVID-19 resurges in India, the country’s government has been less willing to see doses leave the country.

Paquette said they were also working with Johnson and Johnson to determine a delivery schedule for its one-dose vaccine. Procurement minster Anita Anand said she earlier this week they expected the first shipments in late April, but the company suffered a manufacturing setback on Wednesday.

Paquette said they don’t believe that issue will impact Canada’s shipments, but she did not have a specific date for deliveries.

The AstraZeneca vaccine is now limited to people over the age of 55 due to new evidence the vaccine can cause potentially fatal blood clots in younger people.

Dr. Howard Njoo, Canada’s deputy chief public health officer said Canada has seen no incidents of the rare blood clots and is limiting the vaccines use purely as a precaution due to evidence in Europe.

He said he understands why Canadians in the approved age group could be hesitant to take the vaccine, but he encouraged people to see it as the system working.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

“I encourage you to recognize this latest adjustment to guidance in the vaccine administration, what it is an outcome of our robust safety monitoring system and ongoing global collaboration,” he said.

Njoo said the vaccine is safe and effective and prevents hospitalizations and deaths. He said any Canadian offered it should take it.

“I have no hesitation in saying that, if the vaccine was offered to me tomorrow I would take it. Certainly this vaccine along with the other three approved vaccines have all been shown to be very effective in preventing serious illness and death.”

• Email: rtumilty@postmedia.com | Twitter:

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Comments

Postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notifications—you will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Roots sees room for expansion in activewear, reports $5.2M Q2 loss and sales drop

Published

 on

 

TORONTO – Roots Corp. may have built its brand on all things comfy and cosy, but its CEO says activewear is now “really becoming a core part” of the brand.

The category, which at Roots spans leggings, tracksuits, sports bras and bike shorts, has seen such sustained double-digit growth that Meghan Roach plans to make it a key part of the business’ future.

“It’s an area … you will see us continue to expand upon,” she told analysts on a Friday call.

The Toronto-based retailer’s push into activewear has taken shape over many years and included several turns as the official designer and supplier of Team Canada’s Olympic uniform.

But consumers have had plenty of choice when it comes to workout gear and other apparel suited to their sporting needs. On top of the slew of athletic brands like Nike and Adidas, shoppers have also gravitated toward Lululemon Athletica Inc., Alo and Vuori, ramping up competition in the activewear category.

Roach feels Roots’ toehold in the category stems from the fit, feel and following its merchandise has cultivated.

“Our product really resonates with (shoppers) because you can wear it through multiple different use cases and occasions,” she said.

“We’ve been seeing customers come back again and again for some of these core products in our activewear collection.”

Her remarks came the same day as Roots revealed it lost $5.2 million in its latest quarter compared with a loss of $5.3 million in the same quarter last year.

The company said the second-quarter loss amounted to 13 cents per diluted share for the quarter ended Aug. 3, the same as a year earlier.

In presenting the results, Roach reminded analysts that the first half of the year is usually “seasonally small,” representing just 30 per cent of the company’s annual sales.

Sales for the second quarter totalled $47.7 million, down from $49.4 million in the same quarter last year.

The move lower came as direct-to-consumer sales amounted to $36.4 million, down from $37.1 million a year earlier, as comparable sales edged down 0.2 per cent.

The numbers reflect the fact that Roots continued to grapple with inventory challenges in the company’s Cooper fleece line that first cropped up in its previous quarter.

Roots recently began to use artificial intelligence to assist with daily inventory replenishments and said more tools helping with allocation will go live in the next quarter.

Beyond that time period, the company intends to keep exploring AI and renovate more of its stores.

It will also re-evaluate its design ranks.

Roots announced Friday that chief product officer Karuna Scheinfeld has stepped down.

Rather than fill the role, the company plans to hire senior level design talent with international experience in the outdoor and activewear sectors who will take on tasks previously done by the chief product officer.

This report by The Canadian Press was first published Sept. 13, 2024.

Companies in this story: (TSX:ROOT)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Talks on today over HandyDART strike affecting vulnerable people in Metro Vancouver

Published

 on

 

VANCOUVER – Mediated talks between the union representing HandyDART workers in Metro Vancouver and its employer, Transdev, are set to resume today as a strike that has stopped most services drags into a second week.

No timeline has been set for the length of the negotiations, but Joe McCann, president of the Amalgamated Transit Union Local 1724, says they are willing to stay there as long as it takes, even if talks drag on all night.

About 600 employees of the door-to-door transit service for people unable to navigate the conventional transit system have been on strike since last Tuesday, pausing service for all but essential medical trips.

Hundreds of drivers rallied outside TransLink’s head office earlier this week, calling for the transportation provider to intervene in the dispute with Transdev, which was contracted to oversee HandyDART service.

Transdev said earlier this week that it will provide a reply to the union’s latest proposal on Thursday.

A statement from the company said it “strongly believes” that their employees deserve fair wages, and that a fair contract “must balance the needs of their employees, clients and taxpayers.”

This report by The Canadian Press was first published Sept. 12, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Transat AT reports $39.9M Q3 loss compared with $57.3M profit a year earlier

Published

 on

 

MONTREAL – Travel company Transat AT Inc. reported a loss in its latest quarter compared with a profit a year earlier as its revenue edged lower.

The parent company of Air Transat says it lost $39.9 million or $1.03 per diluted share in its quarter ended July 31.

The result compared with a profit of $57.3 million or $1.49 per diluted share a year earlier.

Revenue in what was the company’s third quarter totalled $736.2 million, down from $746.3 million in the same quarter last year.

On an adjusted basis, Transat says it lost $1.10 per share in its latest quarter compared with an adjusted profit of $1.10 per share a year earlier.

Transat chief executive Annick Guérard says demand for leisure travel remains healthy, as evidenced by higher traffic, but consumers are increasingly price conscious given the current economic uncertainty.

This report by The Canadian Press was first published Sept. 12, 2024.

Companies in this story: (TSX:TRZ)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version